Study Overview: This study focuses on pancreatic cancer, a disease that affects the pancreas, an organ in your belly. The study involves collecting and analyzing medical data from patients diagnosed with pancreatic cancer. The data will be gathered from EMR, which stands for Electronic Medical Records. These are digital versions of your health records, created by doctors and hospitals. By analyzing this data, researchers hope to learn more about how treatments work and how patients respond to them.

Key Points:

• The study involves past data from 2010 to 2022 and will collect new data from 2023 to 2029.
• Participants must have a clinical diagnosis of pancreatic cancer.
• The study will not include patients whose medical records cannot be reviewed.

By joining, you help researchers understand pancreatic cancer better. This could lead to improved treatments and care for future patients. Participation requires sharing your medical records, but no new treatments or tests will be given as part of this study. There are no known risks, but if you're interested, consider discussing it with your doctor for more information.